Nalaganje...

Biophysical Differences between Chronic Myelogenous Leukemic Quiescent and Proliferating Stem/Progenitor Cells

The treatment of chronic myeloid leukemia (CML), a clonal myeloproliferative disorder has improved recently, but most patients have not yet been cured. Some patients develop resistance to the available tyrosine kinase treatments. Persistence of residual quiescent CML stem cells (LSC) that later resu...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Nanomedicine
Main Authors: Guz, Nataliia V., Patel, Sapan J., Dokukin, Maxim E., Clarkson, Bayard, Sokolov, Igor
Format: Artigo
Jezik:Inglês
Izdano: 2016
Teme:
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC5116407/
https://ncbi.nlm.nih.gov/pubmed/27431055
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.nano.2016.06.016
Oznake: Označite
Brez oznak, prvi označite!